S&P 500   5,013.98 (-0.16%)
DOW   37,793.28 (+0.11%)
QQQ   423.77 (-0.49%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
S&P 500   5,013.98 (-0.16%)
DOW   37,793.28 (+0.11%)
QQQ   423.77 (-0.49%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
S&P 500   5,013.98 (-0.16%)
DOW   37,793.28 (+0.11%)
QQQ   423.77 (-0.49%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)
S&P 500   5,013.98 (-0.16%)
DOW   37,793.28 (+0.11%)
QQQ   423.77 (-0.49%)
AAPL   167.06 (-0.56%)
MSFT   405.16 (-1.62%)
META   501.81 (+1.55%)
GOOGL   156.45 (+0.63%)
AMZN   179.42 (-1.03%)
TSLA   150.63 (-3.10%)
NVDA   847.33 (+0.83%)
AMD   154.68 (+0.43%)
NIO   4.02 (+2.81%)
BABA   68.94 (+0.17%)
T   16.28 (+0.99%)
F   12.04 (+0.00%)
MU   112.27 (-3.49%)
GE   153.93 (-1.12%)
CGC   8.01 (+23.42%)
DIS   112.88 (-0.05%)
AMC   2.92 (-2.01%)
PFE   25.37 (-0.20%)
PYPL   62.25 (-1.60%)
XOM   118.52 (-0.09%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Athene Holding Ltd. stock logo
ATH
Athene
$83.33
$82.69
$40.21
$91.26
$16.01B1.691.28 million shs3.50 million shs
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
$7.99
-0.7%
$0.00
$4.62
$9.10
$258.24M1.62412,244 shs216,302 shs
MEQ
Mainstreet Equity
$0.00
$0.00
$0.00
N/AN/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
$0.05
$0.05
$0.25
$3.56
$1.48M2.34455,220 shs2,050 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Athene Holding Ltd. stock logo
ATH
Athene
0.00%0.00%0.00%0.00%0.00%
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
0.00%0.00%0.00%0.00%-99.13%
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
+7.53%+4.17%+7.53%+11.11%-99.25%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Athene Holding Ltd. stock logo
ATH
Athene
N/AN/AN/AN/AN/AN/AN/AN/A
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
1.1611 of 5 stars
2.05.00.00.03.40.00.6
MEQ
Mainstreet Equity
N/AN/AN/AN/AN/AN/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Athene Holding Ltd. stock logo
ATH
Athene
N/AN/AN/AN/A
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
2.00
Hold$10.0025.16% Upside
MEQ
Mainstreet Equity
N/AN/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/AN/AN/AN/A

Current Analyst Ratings

Latest MEQ, SQZ, ATH, SEPL, and GTE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/13/2024
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$9.00 ➝ $10.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Athene Holding Ltd. stock logo
ATH
Athene
$14.76B1.08$9.00 per share9.26$105.33 per share0.79
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
$636.96M0.41$6.66 per share1.20$12.29 per share0.65
MEQ
Mainstreet Equity
N/AN/AN/AN/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
$18.16M0.08N/AN/A$1.94 per share0.03

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Athene Holding Ltd. stock logo
ATH
Athene
$1.54B$18.944.409.09N/A13.69%14.35%1.40%N/A
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
-$6.29M-$0.20N/AN/A-0.99%-1.60%-0.47%4/30/2024 (Estimated)
MEQ
Mainstreet Equity
N/AN/A0.00N/AN/AN/AN/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
-$79.46M-$2.61N/AN/AN/A-369.96%-119.83%-59.90%N/A

Latest MEQ, SQZ, ATH, SEPL, and GTE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/20/202412/31/2023
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
-$0.10$0.23+$0.33$0.23N/A$154.94 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Athene Holding Ltd. stock logo
ATH
Athene
N/AN/AN/AN/AN/A
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
N/AN/AN/AN/AN/A
MEQ
Mainstreet Equity
N/AN/AN/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Athene Holding Ltd. stock logo
ATH
Athene
0.11
0.65
0.65
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
1.31
0.43
0.32
MEQ
Mainstreet Equity
N/AN/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/A
3.50
3.50

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Athene Holding Ltd. stock logo
ATH
Athene
85.87%
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
31.70%
MEQ
Mainstreet Equity
N/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
38.51%

Insider Ownership

CompanyInsider Ownership
Athene Holding Ltd. stock logo
ATH
Athene
6.80%
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
6.45%
MEQ
Mainstreet Equity
N/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
16.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Athene Holding Ltd. stock logo
ATH
Athene
1,350192.14 million179.08 millionOptionable
Gran Tierra Energy Inc. stock logo
GTE
Gran Tierra Energy
35132.32 million30.23 millionNot Optionable
MEQ
Mainstreet Equity
N/AN/AN/ANot Optionable
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
5329.49 million24.77 millionNot Optionable

MEQ, SQZ, ATH, SEPL, and GTE Headlines

SourceHeadline
VC funding update: who raised money in March?VC funding update: who raised money in March?
bizjournals.com - April 1 at 11:06 AM
SQZ, Portal founder Armon Sharei on starting over in biotechSQZ, Portal founder Armon Sharei on starting over in biotech
biopharmadive.com - March 26 at 10:35 AM
Portal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VCPortal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VC
finance.yahoo.com - March 19 at 10:20 AM
SQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to StemcellSQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to Stemcell
fiercebiotech.com - March 1 at 10:56 AM
Rx Rundown: Gilead Sciences, Latigo Biotherapeutics, Exscientia and moreRx Rundown: Gilead Sciences, Latigo Biotherapeutics, Exscientia and more
mmm-online.com - February 16 at 8:05 AM
SQZB SQZ Biotechnologies CompanySQZB SQZ Biotechnologies Company
seekingalpha.com - December 28 at 1:42 PM
SQZ Biotechnologies Co Ordinary Shares SQZBSQZ Biotechnologies Co Ordinary Shares SQZB
morningstar.com - December 12 at 8:37 PM
SQZ founder Armon Sharei opens Portal to to simplify intracellular deliverySQZ founder Armon Sharei opens Portal to to simplify intracellular delivery
fiercebiotech.com - December 12 at 10:35 AM
Medicine at a bigger scale: FUJIFILM Diosynth Biotechnologies unveils new Holly Springs drug manufacturing site'Medicine at a bigger scale': FUJIFILM Diosynth Biotechnologies unveils new Holly Springs drug manufacturing site
wral.com - November 11 at 8:41 PM
‘Difficult but necessary steps’: SQZ lays off 80% of staff, RegenXBio cuts 15%‘Difficult but necessary steps’: SQZ lays off 80% of staff, RegenXBio cuts 15%
fiercebiotech.com - November 9 at 10:34 AM
SQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio UpdatesSQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio Updates
finance.yahoo.com - November 8 at 6:33 PM
SQZ Biotechnologies GAAP EPS of -$0.80 misses by $0.30, revenue of $0MSQZ Biotechnologies GAAP EPS of -$0.80 misses by $0.30, revenue of $0M
msn.com - November 8 at 6:33 PM
Lifeline Biotechnologies Inc LLBOLifeline Biotechnologies Inc LLBO
morningstar.com - November 4 at 11:41 PM
SQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual MeetingSQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual Meeting
finance.yahoo.com - November 3 at 7:42 PM
SQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio UpdatesSQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio Updates
finance.yahoo.com - August 10 at 9:16 PM
Sqz Biotechnologies Co (SQZB)Sqz Biotechnologies Co (SQZB)
investing.com - August 3 at 7:45 AM
Roche declines to take up option on SQZ Bio’s SQZ-APC-HPV programRoche declines to take up option on SQZ Bio’s SQZ-APC-HPV program
thepharmaletter.com - July 27 at 12:11 AM
Roche Passes on Option to Advance Cell Therapy in HPV-Positive Tumors With SQZ BiotechnologiesRoche Passes on Option to Advance Cell Therapy in HPV-Positive Tumors With SQZ Biotechnologies
precisionmedicineonline.com - July 25 at 10:53 PM
Roche Decides Not to Exercise Solid Tumor Option with SQZRoche Decides Not to Exercise Solid Tumor Option with SQZ
biospace.com - July 25 at 10:53 PM
SQZ Biotechnologies Provides Update on Collaboration with RocheSQZ Biotechnologies Provides Update on Collaboration with Roche
benzinga.com - July 25 at 12:37 PM
Roche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurchRoche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurch
pharmaceutical-technology.com - July 25 at 12:37 PM
Understanding the Risks of Investing in SQZ Biotechnologies Company (SQZ)Understanding the Risks of Investing in SQZ Biotechnologies Company (SQZ)
knoxdaily.com - July 5 at 1:10 PM
SQZ Biotechnologies to be delisted from the NYSESQZ Biotechnologies to be delisted from the NYSE
seekingalpha.com - July 3 at 11:23 PM
NYSE to Commence Delisting Proceedings Against SQZ Biotechnologies Company (SQZ)NYSE to Commence Delisting Proceedings Against SQZ Biotechnologies Company (SQZ)
finance.yahoo.com - July 3 at 6:23 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Athene logo

Athene

NYSE:ATH
Athene Holding Ltd. is engages in the provision of retirement services. The firm issues, reinsures and acquires retirement savings products and institutional products. It operates through following segments: Retirement Services, and Corporate and Other. The Retirement Services segment is comprised of US and Bermuda operations, which issue and reinsure retirement savings products and institutional products. The Corporate and Other segment includes corporate activities such as corporate allocated expenses, merger and acquisition costs, debt costs, preferred stock dividends, certain integration and restructuring costs, certain stock-based compensation and intersegment eliminations. The company was founded by James R. Belardi and Frank L. Gills in May 2009 and is headquartered in Pembroke, Bermuda.
Gran Tierra Energy logo

Gran Tierra Energy

NYSEAMERICAN:GTE
Gran Tierra Energy Inc., together with its subsidiaries, engages in the exploration and production of oil and gas properties in Colombia and Ecuador. The company was founded in 2003 and is headquartered in Calgary, Canada.

Mainstreet Equity

NYSE:MEQ
SQZ Biotechnologies logo

SQZ Biotechnologies

NYSE:SQZ
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.